Protective Effects of Platycodin D on Lipopolysaccharide-Induced Acute Lung Injury by Activating LXRα–ABCA1 Signaling Pathway by Xiaoyu Hu et al.
January 2017 | Volume 7 | Article 6441
Original research
published: 03 January 2017
doi: 10.3389/fimmu.2016.00644
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Pietro Ghezzi, 
Brighton and Sussex Medical 
School, UK
Reviewed by: 
Thomas Daniel Nightingale, 
Queen Mary University of London, 
UK  
Christopher Pattillo, 
LSU Health Sciences Center 
New Orleans, USA
*Correspondence:
Yongguo Cao  
ygcao82@jlu.edu.cn; 
Naisheng Zhang  
zhangns@jlu.edu.cn
†These authors have contributed 
equally to this article.
Specialty section: 
This article was submitted to 
Inflammation, a section of the 
journal Frontiers in Immunology
Received: 13 July 2016
Accepted: 13 December 2016
Published: 03 January 2017
Citation: 
Hu X, Fu Y, Lu X, Zhang Z, Zhang W, 
Cao Y and Zhang N (2017) Protective 
Effects of Platycodin 
D on Lipopolysaccharide-Induced 
Acute Lung Injury by Activating 
LXRα–ABCA1 Signaling Pathway. 
Front. Immunol. 7:644. 
doi: 10.3389/fimmu.2016.00644
Protective effects of Platycodin  
D on lipopolysaccharide-induced 
acute lung injury by activating  
lXrα–aBca1 signaling Pathway
Xiaoyu Hu†, Yunhe Fu†, Xiaojie Lu, Zecai Zhang, Wenlong Zhang, Yongguo Cao* and 
Naisheng Zhang*
Department of Clinical Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, China
The purpose of this study was to investigate the protective effects of platycodin D (PLD) 
on lipopolysaccharide (LPS)-induced acute lung injury (ALI) and clarify the possible mech-
anism. An LPS-induced ALI model was used to confirm the anti-inflammatory activity 
of PLD in  vivo. The A549 lung epithelial cells were used to investigate the molecular 
mechanism and targets of PLD in vitro. In vivo, the results showed that PLD significantly 
attenuated lung histopathologic changes, myeloperoxidase activity, and pro-inflammatory 
cytokines levels, including TNF-α, IL-1β, and IL-6. In vitro, PLD inhibited LPS-induced IL-6 
and IL-8 production in LPS-stimulated A549 lung epithelial cells. Western blot analysis 
showed that PLD suppressed LPS-induced NF-κB and IRF3 activation. Moreover, PLD 
did not act though affecting the expression of TLR4. We also showed that PLD disrupted 
the formation of lipid rafts by depleting cholesterol and prevented LPS-induced TLR4 
trafficking to lipid rafts, thereby blocking LPS-induced inflammatory response. Finally, 
PLD activated LXRα–ABCA1-dependent cholesterol efflux. Knockdown of LXRα abro-
gated the anti-inflammatory effects of PLD. The anti-inflammatory effects of PLD was 
associated with upregulation of the LXRα–ABCA1 pathway, which resulted in disrupting 
lipid rafts by depleting cholesterol and reducing translocation of TLR4 to lipid rafts.
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inTrODUcTiOn
Acute lung injury (ALI) takes responsibility for significant morbidity and is associated with an up to 
30–50% mortality rate (1). The epithelial cells played an important role in innate immune responses. 
It not only provides a physico-chemical barrier but also responds to inhaled microorganisms by 
releasing inflammatory mediators (2). Lipopolysaccharide (LPS) activates TLR4 signaling pathway 
and triggers an inflammatory response in ALI (3). ABCA1 is a lipid pump that effluxes cholesterol 
and phospholipid out of cells. Activation of ABCA1 and ABCG1 could induce cholesterol efflux 
from plasma membrane microdomains known as lipid rafts (4). Lipid rafts, enriched in cholesterol 
and sphingolipids, are microdomains of the plasma membrane. They serve as a platform for signal 
transduction and play an important role in TLR4 signal pathway (5). Treatment with raft-disrupting 
drugs could suppress LPS-induced NF-κB activation and TNF-α production (6, 7).
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Platycodin D (PLD), the major triterpene saponin in the root 
of Platycodon grandiflorum, has been reported to have various 
pharmacological activities. PLD exhibited a broad spectrum anti-
inflammatory effect. PLD could inhibit LPS-induced TNF-α and 
IL-1β production in RAW264.7 cells (8). PLD could inhibit NF-κB 
activation (9). Furthermore, PLD was found to attenuate airway 
inflammation by inhibiting NF-κB activation (10). However, the 
effects of PLD on LPS-induced ALI and the molecular targets 
remain unclear. The purpose of this work was to examine the 
anti-inflammatory effects of PLD in LPS-induced ALI and to 
identify the molecular targets of PLD in A549 lung epithelial cells.
MaTerials anD MeThODs
Materials
Platycodin D was purchased from the National Institute for the 
Control of Pharmaceutical and Biological Products (Beijing, 
China). Dimethyl sulfoxide (DMSO), LPS (Escherichia coli 
055:B5), and 3-(4,5-dimethylthiazol-2-y1)-2,5-diphenyltetra-
zolium bromide (MTT) were purchased from Sigma Chemical 
Co. (St. Louis, MO, USA). Human TNF–α, IL-6, IL-1β, and 
IL-8 ELISA kits were purchased from Biolegend (CA, USA). 
Human mAb Phospho-NF-κB and human mAb NF-κB, human 
mAb Phospho-IRF3, and mAb IRF3 were purchased from Cell 
Signaling Technology Inc. (Beverly, MA, USA). β-actin was pur-
chased from Tianjin Sungene Biotech Co. Ltd. (Tianjin, China). 
All other chemicals were of reagent grade.
animals and Treatment
All animal experiments were performed in accordance with the 
guide for the Care and Use of Laboratory Animals published 
by the US National Institute of Health. Male BALB/c mice 
(8–12 weeks), which weighed 18–20 g, were purchased from the 
Center of Experimental Animals of Baiqiuen Medical College of 
Jilin University (Jilin, China). All animals were housed in microi-
solator cages and received food and water ad libitum. Laboratory 
temperature was 24 ± 1°C, and relative humidity was 40–80%. 
Before experimentation, mice were housed for a minimum of 
4–6 days to adapt them to the environment.
All mice were randomly divided into the following groups: 
control group, LPS group, PLD (20, 40, and 80  mg/kg) +  LPS 
groups, and dexamethasone (DEX) + LPS group. PLD and DEX 
were intraperitoneally injected before stimulation with LPS. 
Meanwhile, control and LPS groups were administrated with an 
equal volume of distilled water. One hour later, 10 µg of LPS in 
50 µl of PBS was introduced intranasally (i.n.) to produce ALI. 
Control mice received 50 µl PBS. Mice were humanely sacrificed 
7  h after LPS stimulation. Mice all underwent combined with 
tracheal intubation and bronchoalveolar lavage fluid (BALF) 
were repeatedly collected for analysis.
histopathologic evaluation  
of the lung Tissue
Histopathologic examination was performed on mice that 
were not subjected to BALF collection. Seven hours after LPS 
treatment, lungs tissues were collected and fully fixed with 10% 
buffered formalin for approximately 1 week. The lung tissues 
were embedded in paraffin and cut into 5  µm sections, fol-
lowed by hematoxylin and eosin (H&E) staining. Pathological 
changes in the lungs were examined with light microscope 
(Olympus, Japan).
inflammatory cell counts of BalF
The BALF samples were collected and centrifuged at 3,000 rpm 
for 10 min at 4°C. The cells were resuspended in PBS for the total 
cell counts using a hemacytometer, and cytospins were prepared 
for differential cell counts by staining with the Wright–Giemsa 
staining method (11).
Pulmonary Myeloperoxidase (MPO) 
activity in ali Mice
The MPO activity in homogenates of lung tissues was evalu-
ated using MPO test kits (Nanjing Jiancheng Bioengineering 
Institute). Briefly, the mice were killed 7 h after treatment with 
LPS. The lung tissues were collected to make 5% homogenate with 
extraction buffer, followed by constitute with 0.9 ml homogenate 
and 0.1 ml reaction buffer was hated to 37°C in water for 15 min. 
The enzymatic activity was tested by automatic microplate reader 
(Tecan Sunrise) in absorbance at 460 nm.
cell culture and Treatment
The human lung epithelial cell line A549 was obtained from 
American Type Culture Collection (ATCC, Manassas, VA, USA) 
and maintained in DMEM supplemented with 10% fetal bovine 
serum (FBS) at 37°C with 5% CO2. HEK293T cells, purchased 
from ATCC (Manassas, VA, USA), were cultured in DMEM 
(Invitrogen) containing 10% FBS at 37°C with 5% CO2.
cell Viability assay
The cell viability was measured by MTT assay. A549 cells were 
plated at a density of 4 × 105 cells/ml in 96-well plates for 1 h, then 
the cells were treated with 50 µl of PLD at different concentrations 
(0–20 µM) for 1 h, followed by stimulation with 50 µl LPS. After 
18 h of LPS stimulation, 20 µl MTT (5 mg/ml) was added to each 
well, and the cells were further incubated for an additional 4 h. 
The supernatant was removed and the formation of formazan 
was resolved with 150 μl/well of DMSO. The optical density was 
measured at 570 nm on a microplate reader (TECAN, Austria).
elisa assay
The A549 lung epithelial cells were treated with or without PLD 
(5, 10, and 20 µM). One hour later, the cells were treated with 
LPS for another 24  h. The sample was centrifuged (2,000  rpm 
for 40  min at 4°C), and supernatant was collected to measure 
the levels of cytokines IL-6 and IL-8 by ELISA according to the 
manufacturer’s protocols (BioLegend). Read plate at 570 nm by 
automatic microplate reader (Tecan Sunrise).
Western Blot analysis
Total proteins within cells were extracted using the M-PER 
Mammalian Protein Extracted Reagent (Thermo). The concen-
tration of protein was measured through a BCA protein assay kit 
FigUre 1 | histopathologic sections of lung tissues (he, ×100), lung 
tissue of control group (a), lipopolysaccharide (lPs) group (B), 
lPs + DeX group (c), lPs + platycodin D (PlD) 20 mg/kg (D), 
lPs + PlD 40 mg/kg (e), and lPs + PlD 80 mg/kg (F).
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(Pierce, Rockford, IL, USA). Lysate samples which contain same 
amounts of protein (40 µg) were fractionated by SDS-PAGE and 
then transferred onto a PVDF membrane. We blocked the mem-
brane with 5% skimmed milk at room temperature continuing for 
2 h, which was as well probed with primary antibodies (1:1,000 
dilutions in TBS-T) at 4°C overnight. The membrane was washed 
with PBS-T for three times. After that, another 1 h was needed 
to incubate the membrane with specific secondary antibody at 
room temperature. The targeted proteins could be seen with 
Supersignal West Pico Chemiluminescent Substrate (Thermo 
Scientific, USA). The β-actin protein played a role as an internal 
control. The density of each band was quantified using image 
analysis software (Image J). The protein levels were normalized 
to β-actin.
immunocytochemistry and  
lipid rafts staining
Cell membrane lipid rafts were labeled with choleratoxin subunit 
B (CTxB). Cells were fixed in 4% formaldehyde for 40  min at 
room temperature. Then, it was incubated with Alexa Fluor 
488-conjugated CTxB (5  µg/ml) for 20  min and washed with 
PBST three times. Cells were stained with Hochest for 5  min. 
The fluorescent images were obtained using scanning confocal 
microscope (Olympus FluoView FV1000).
isolation of lipid rafts
Lipid rafts were isolated, as described previously (12). Briefly, 
A549 cells were lysed in ice-cold MBS buffer (25 mM MES, pH 
6.5, 150 mM NaCl, 1 mM Na3VO4, 1% Triton X-100, and pro-
tease inhibitors). Lysates were mixed with 4 ml of 40% sucrose 
by mixing with 2 ml of 80% sucrose and overlaid with 4 ml of 
35% sucrose and 4 ml of 5% sucrose in MBS buffer. Samples were 
ultracentrifuged at 39,000 rpm for 18 h and fractionated into 12 
subfractions.
Quantification of cholesterol levels  
in lipid rafts of a549 cells
Lipid rafts were isolated as described above. Cholesterol level of 
lipid raft was assayed by gas–liquid chromatography, as previ-
ously described (13).
cholesterol replenishment experiment
A549 cells were treated with culture medium alone or medium 
containing PLD (3, 6, and 12 µM), or MβCD (10 mM) at 37°C 
for 60  min. Subsequently, the cells were washed with PBS and 
incubated 30  min with medium or medium containing water-
soluble cholesterol (84 µg/ml). Then, the cells were treated with 
LPS. The effect of PLD on LPS-induced cytokines was detected, 
as mentioned above.
lXr receptor gene assay
For LXR activation assay, A549 cells were transfected with 
0.75 µg of LXRE-driven luciferase reporter vector (LXRE-tk-Luc) 
and 0.75  µg of β-galactosidase control vector (Promega) using 
FuGENE HP transfection reagent. Six hours later, A549 cells 
were incubated with PLD for 12 h. The β-galactosidase enzyme 
activity was measured using the β-galactosidase Enzyme System 
(GloMax-96 Microplate Luminometer, Promega).
Transient Transfection of sirna  
against lXrα
siRNA against LXRα (si-LXRα; ON-TARGET plus SMART pool), 
non-targeting siRNA (si-control), and the DharmaFECT transfec-
tion reagent was purchased from Thermo Scientific Dharmacon 
(USA). Si-LXRα and si-control stock solutions (20  µM) were 
solved with DEPC water to form 5 µM solutions. When the cells 
reached to 60% confluency, the transfection reagent was mixed 
with 5 µM si-LXRα or si-control for 20 min. Then, it was added to 
the medium to reach the concentration of 25 µM. The A549 cells 
were treated with siRNA for 48 h. The effects of siRNA on LXRα 
were detected by western blot analysis.
statistical analysis
All values are expressed as the means ± SEM. Differences between 
groups were analyzed using a one-way ANOVA (Dunnett’s t-test) 
and a two-tailed Student’s t-test. The results were considered 
statistically significant at p < 0.05 or p < 0.01.
resUlTs
effects of PlD on lPs-Mediated lung 
histopathologic changes
To investigate the protective effects of PLD on LPS-induced ALI, 
lung pathologic changes were determined by H&E staining. As 
shown in Figure 1, lung tissues from the control group showed 
a normal structure and no histopathologic changes under a light 
microscope (Figure  1A). While, lung of mice administered by 
LPS showed several obvious inflammatory histological changes, 
such as pulmonary congestion, focal area of fibrosis with collapse 
of air alveoli and emphysematous, thickening of the alveolar wall, 
FigUre 2 | (a) Effects of platycodin D on the number of total cells, neutrophils, and macrophages in the BALF of lipopolysaccharide (LPS)-induced ALI mice. BALF 
was collected at 7 h after LPS administration to measure the number of total cells, neutrophils, and macrophage. (B) The levels of TNF-α, IL-1β, and IL-6 in the 
BALF. Data are presented as mean ± SEM (n = 12 in each group) and differences between mean values were assessed by one-way ANOVA (Dunnett’s t-test) and 
the two-tailed Student’s t-test. #p < 0.01 significantly different from control group; *p < 0.05 and **p < 0.01 significantly different from LPS group.
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and areas of inflammatory infiltration (Figure  1B). However, 
LPS-induced pathological changes were significantly attenuated 
by PLD (20, 40, and 80 mg/kg) (Figures 1D–F) and DEX (5 mg/
kg) treatment (Figure 1C).
effects of PlD on inflammatory cell count 
in the BalF of lPs-induced ali Mice
To investigate the effects of PLD on inflammatory cell infiltra-
tion, the numbers of inflammatory cells, such as neutrophils and 
macrophages, in BALF were analyzed by Wright–Giemsa stain-
ing method. As shown in Figure 2A, LPS challenge significantly 
increased the number of total cells, neutrophils and macrophages 
compared with the control group (p < 0.01). Meanwhile, pretreat-
ment with PLD (20, 40, and 80 mg/kg) and DEX (5 mg/kg) was 
found to significantly decrease the number of total cells (p < 0.01), 
neutrophils (p < 0.01), and macrophages (p < 0.01).
effects of PlD on cytokine Production in 
the BalF of lPs-Treated ali Mice
To investigate the anti-inflammatory effects of PLD, we measured 
changes in inflammatory cytokines TNF-α, IL-1β and IL-6 in 
BALF. As shown in Figure  2B, stimulation with LPS caused a 
noticeable lift of TNF-α (*p < 0.05), IL-1β (*p < 0.05 or **p < 0.01), 
and IL-6 (*p < 0.05 or **p < 0.01) compared with control group, 
while the one with pretreatment of PLD (20, 40, and 80 mg/kg) 
and DEX, it is the number of TNF-α, IL-1β, and IL-6 induced by 
LPS is dependently suppressed.
effects of PlD on the MPO activity in ali 
Mice induced by lPs
PMNs are the major components of inflammatory and immuno-
logical reactions in injured lungs. MPO activity served as a marker 
of PMN accumulation in the lung. As shown in Figure 3A, lung 
FigUre 3 | (a) Effects of platycodin D (PLD) on myeloperoxidase (MPO) 
activity in lung tissues of lipopolysaccharide (LPS)-induced ALI. MPO activity 
was determined at 7 h after LPS administration. (B). Effect of PLD on the cell 
viability of A549 lung epithelial cells. The cell viability was determined by MTT 
assay. The values presented are the means ± SEM of three independent 
experiments, and differences between mean values were assessed by 
one-way ANOVA (Dunnett’s t-test) and the two-tailed Student’s t-test. 
#p < 0.01 vs. control group, *p < 0.05, **p < 0.01 vs. LPS group.
FigUre 4 | Platycodin D inhibits lipopolysaccharide (lPs)-induced 
cytokine production in a dose-dependent manner. Levels of IL-6 and 
IL-8 in culture supernatants were measured by ELISA. The data presented 
are the means ± SEM of three independent experiments, and differences 
between mean values were assessed by ANOVA. #p < 0.05 vs. control 
group; *p < 0.05, **p < 0.01 vs. LPS group.
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MPO activity was upregulated after LPS treatment compared 
with control group (p < 0.01). However, PLD (20, 40, ad 80 mg/
kg) (p < 0.01) and DEX (5 mg/kg) (p < 0.01) treatment prevented 
elevated MPO activity after LPS stimulation.
effects of PlD on cell Viability
MTT assay was used to test the effect of PLD on the potential 
cytotoxicity of cell. As shown in Figure 3B, cell viabilities were 
not affected by the PLD (5, 10, and 20 µM) at concentrations used. 
Thus, the effects of PLD on A549 cells were not attributable to 
cytotoxic effects.
effects of PlD on lPs-induced  
cytokine Production
To investigate the protective effects of PLD in vitro, the produc-
tion of IL-6 and IL-8 in the culture supernatants of A549 cells 
were measured by ELISA. As shown in Figure 4, the production 
of IL-6 and IL-8 increased after LPS stimulation. However, 
PLD significantly suppressed IL-6 and IL-8 production in LPS-
stimulated A549 cells (Figure 4).
effects of PlD on lPs-induced nF-κB  
and irF3 activation
To test whether the anti-inflammatory effect of PLD is mediated 
through the NF-κB and IRF3 pathway, we measured the expres-
sion of NF-κB and IRF3 protein by Western blotting. As shown in 
Figure 5A, LPS significantly induced NF-κB and IRF3 activation 
in A549 cells. However, PLD significantly inhibited NF-κB and 
IRF3 activation induced by LPS.
PlD Does not act through  
affecting the expression of Tlr4
TLR4 is the upstream molecule of NF-κB and IRF3. Meanwhile, 
TLR4 is the major receptor of LPS. Therefore, we investigated 
whether PLD inhibited LPS-induced inflammatory response by 
suppressing TLR4 expression. As shown in Figure 5B, the results 
showed that LPS significantly elevated the expression of TLR4. 
FigUre 5 | (a) Platycodin D (PLD) inhibits lipopolysaccharide (LPS)-induced NF-κB and IRF3 activation. A549 cells were preincubated with PLD (5, 10, and 20 µM) 
for 1 h and then treated with 1 µg/ml LPS for 1 h. (B) PLD does not affect TLR4 expression. Cells were preincubated with PLD (5, 10, and 20 µM) for 1 h and then 
treated with 1 µg/ml LPS for 6 h. Protein samples were analyzed by western blot with specific antibodies. The gels have been run under the same experimental 
conditions. The data presented are the means ± SEM of three independent experiments, and differences between mean values were assessed by one-way ANOVA 
and the two-tailed Student’s t-test. #p < 0.05 vs. control group; *p < 0.05, **p < 0.01 vs. LPS group.
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PLD did not affect the expression of TLR4 upregulated by LPS 
(Figure 5B).
PlD inhibits Translocation of  
Tlr4 to lipid rafts
Lipid rafts played an important role in LPS/TLR4 signaling pathway. 
Stimulating cells with LPS could induce TLR4 recruit to lipid rafts. 
To further address the potential anti-inflammatory mechanism 
of PLD, we determined the effects of PLD on the recruitment of 
TLR4 into lipid rafts. We isolated raft fractions and examined the 
translocation of TLR4 by immunoblotting. The results showed that 
LPS stimulation induced localization of TLR4 to raft fractions. PLD 
or MβCD reduced TLR4 recruitment into lipid rafts (Figure 6).
PlD Disrupts the Formation of lipid rafts 
in cell Membranes by Depleting 
cholesterol
Previous studies showed that inhibition the formation of lipid 
rafts could prevent translocation of TLR4 to lipid rafts. GM1 
has been known to be a marker of lipid rafts. To investigate the 
FigUre 6 | The recruitment of Tlr4 to lipid rafts was inhibited by platycodin D (PlD). (a) A549 cells were pretreated with PLD or MβCD, followed by 
treatment with 1 μg/ml lipopolysaccharide (LPS). The cells were lysed and subjected to discontinuous sucrose density gradient centrifugation as described in 
Section “Materials and Methods.” Fractions 3–4 correspond to lipid rafts. Representative blots of six separate experiments are shown. Fractions 9–12 correspond to 
non-lipid rafts. (B) TLR4 content of macrophage lipid rafts was calculated as a percentage of total membrane TLR4 (lipid rafts + non-rafts). The values presented are 
the means ± SEM of three independent experiments, and differences between mean values were assessed by Students’s t-test. The gels have been run under the 
same experimental conditions. #p < 0.05 vs. control group; *p < 0.05, **p < 0.01 vs. LPS group.
FigUre 7 | The inhibition of the formation of lipid rafts by platycodin 
D (PlD). The cells were preincubated with PLD (5, 10, and 20 µM) for 1 h, 
followed by treatment with 1 µg/ml lipopolysaccharide (LPS) for 6 h. The lipid 
rafts (green) were stained with Alexa Flour 488-conjugated CTxB, and the 
nucleus was stained with Hochest. (a) Control group, (B) LPS group, 
(c) LPS + MβCD group, (D) LPS + PLD 12 µM, (e) LPS + PLD 6 µM, and 
(F) LPS + PLD 3 µM.
FigUre 8 | effects of platycodin D (PlD) on membrane lipid rafts 
cholesterol levels. A549 cells were treated with PLD (5, 10, and 20 µM) for 
12 h. Membrane cholesterol levels were measured by gas–liquid 
chromatography, and the results were plotted as microgram cholesterol per 
milligram protein. The values presented are the means ± SEM of three 
independent experiments, and differences between mean values were 
assessed by Students’s t-test (*p < 0.05, **p < 0.01).
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anti-inflammatory mechanism of PLD, the formation of lipid 
rafts were tested by assessing GM-1 expression by confocal laser 
microscopy. PLD disrupted the formation of lipid rafts by deplet-
ing cholesterol (Figure  7). Meanwhile, the results showed that 
PLD disrupted the lipid rafts by removing of cholesterol from 
lipid rafts in a dose-dependent manner (Figure 8).
cholesterol replenishment Prevents the 
anti-inflammatory effect of PlD
Cholesterol replenishment experiments were used to clarify 
the mechanism of PLD. As shown in Figure  9, the inhibition 
effect of PLD on LPS-induced cytokines production was 
abolished.
PlD activates lXrα and aBca1
Activation of LXRα could regulate intracellular cholesterol lev-
els. Thus, we performed a luciferase reporter gene assay to test 
whether PLD could enhance transcriptional activity of LXRα. 
As shown in Figure  10A, PLD dose-dependently increased 
expression of the LXR luciferase reporter gene. Meanwhile, the 
expression of ABCA1 was detected by Western blot analysis. As 
FigUre 9 | a549 cells were treated with culture medium alone or 
medium containing platycodin D (20 µM), or MβcD (10 mM) at 37°c 
for 60 min. Subsequently, the cells were washed with PBS and incubated 
with medium alone or medium containing water-soluble cholesterol (84 µg/
ml) for 30 min. Cells were treated with 1 µg/ml lipopolysaccharide (LPS) for 
24 h. Levels of IL-6 and IL-8 in culture supernatants were measured by 
ELISA. The data presented are the means ± SEM of three independent 
experiments, and differences between mean values were assessed by 
ANOVA. #p < 0.05 vs. control group; *p < 0.05, **p < 0.01 vs. LPS group.
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shown in Figure 10B, PLD upregulated the expression of ABCA1 
in a dose-dependent manner.
Knockdown of lXrα abrogated the 
effects of PlD on lPs induced 
inflammatory response
We tested whether the anti-inflammatory mechanism of PLD 
is through LXRα, LXRα was silenced using specific siRNA. The 
results showed that the expression of LXRα was significantly 
inhibited by siRNA. Once LXRα was knockdown, the effects of 
PLD on cholesterol levels and cytokines production induced by 
LPS were reversed (Figure 11).
DiscUssiOn
Acute lung injury, or its severe form ARDS, is characterized 
by the release of inflammatory mediators (14). Previous study 
showed that PLD could protect against airway inflammation (10). 
In this study, our results showed that PLD significantly attenuated 
LPS-induced lung damage. In vitro, PLD inhibited the production 
of cytokines by reducing TLR4 migration into lipid rafts in LPS-
activated A549 lung epithelial cells.
Myeloperoxidase activity is assessed for the quantification of 
neutrophil accumulation in tissues (15). In this study, we found 
that treatment with PLD significantly decreased LPS-induced 
increases in MPO activity in the lung tissues compared with 
the LPS group. Histologic observation demonstrated marked 
thickening of the alveolus walls and significant infiltration of 
inflammatory cells in LPS-induced ALI. Administration of PLD 
remarkably attenuated lung pathological changes. These results 
showed that PLD had a protective effect against LPS-induced ALI.
The lung epithelial cells provide a physical barrier and play an 
important role in defense against invading microbial pathogens 
(16). The lung epithelial cells recognize various pathogens and 
respond by secreting chemokines and cytokines to alert innate 
and adaptive immune system to prevent and control infection. 
Studies showed that stimulation of lung epithelial cells by LPS 
could induce TNF-α, IL-8, and IL-6 production (17, 18). These 
cytokines and chemokines play important roles in the progress of 
ALI (19). In this study, our results showed that PLD dose-depend-
ently inhibited IL-8, and IL-6 production in LPS-stimulated A549 
lung epithelial cells.
Activation of TLR4 by LPS leads to NF-κB and IRF3 activa-
tion and cytokines release (20). NF-κB and IRF3 play important 
roles in regulating inflammatory cytokines production. To test 
the inhibitory mechanism of cytokines production, the effects 
of PLD on NF-κB and IRF3 activation were measured. Our 
results suggested that PLD could inhibit LPS-induced NF-κB and 
IRF3 activation in a dose-dependent manner. This was consist-
ent with previous study which showed PLD protected against 
OVA-induced asthma by inhibiting NF-κB activation (10). The 
effect of PLD on TLR4 expression was tested to investigate the 
mechanism of PLD. The results showed that PLD did not inhibit 
TLR4 expression.
Lipid rafts are detergent insoluble glycolipid-enriched mem-
brance domains. Lipid rafts play a critical role in TLR4 signal-
ing pathway (21). In this study, our results demonstrated that 
PLD inhibited translocation of TLR4 to lipid rafts (Figure  8). 
Meanwhile, the results in Figures  8 and 9 showed that PLD 
disrupted the formation of lipid rafts by depleting cholesterol. 
Studies showed that treatment with raft-disrupting drugs (deplet-
ing cholesterol) could inhibit TLR4 translocation into lipid rafts 
and LPS induced NF-κB activation and TNF-α production (6, 
7). It is suggested that PLD disrupts lipid rafts by depleting cho-
lesterol. And the disruption of lipid rafts leads to the inhibition 
of TLR4 translocation to lipid raft in A549 lung epithelial cells. 
Cholesterol replenishment prevents the anti-inflammatory effect 
of PLD.
LXRs regulate intracellular cholesterol levels through ATP-
binding cassette transporter A1 (ABCA1). ABCA1, located 
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FigUre 10 | (a) Effects of platycodin D (PLD) on LXRα transcriptional activity. Relative luciferase activity was determined by normalization with β-galactosidase 
activity. The data are normalized to control group (*p < 0.05, **p < 0.01). (B) Effects of PLD on ABCA1 expression. The values presented are the means ± SEM of 
three independent experiments, and differences between mean values were assessed by Students’s t-test (*p < 0.05, **p < 0.01). The gels have been run under the 
same experimental conditions. #p < 0.05 vs. control group; *p < 0.05, **p < 0.01 vs. lipopolysaccharide group.
FigUre 11 | (a) Cells were transfected with a siRNA specific for LXRα, or a scrambled siRNA (negative control) as indicated. The effects of siRNA on LXRα 
expression was detected by Western blot analysis. (B) Knockdown of LXRα abrogated the effects of Platycodin D on lipid rafts cholesterol levels, and 
lipopolysaccharide (LPS) induces inflammatory response. A549 cells were transfected with a siRNA specific for LXRα, or a scrambled siRNA (negative control) as 
indicated. Lipid raft cholesterol levels were detected. Levels of IL-8 and IL-6 in culture supernatants were measured by ELISA. The data presented are the 
means ± SEM of three independent experiments, and differences between mean values were assessed by Students’s t-test. #p < 0.05 vs. control group; *p < 0.05, 
**p < 0.01 vs. LPS group.
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